Day 1 - Session 1 - 09:10 - 11:00

Welcome 

Screening Programmes 

Session 1 Chairs: Parth Narendran & Lucy Chambers  

The Italian Experience - Emanuele Bosi, Milan (09:10 - 09:30) 

The US Experience - Marian Rewers, Denver, Colorado  (09:30 - 09:50) 

ELSA - Lauren Quinn, Birmingham  (09:50 - 10:10) 

Panel discussion on implementing screening in the UK - All speakers + Primary Care Diabetes Society (10:30 - 11:00)

Day 1 - Session 2 - 11:30 - 12:40

How can genetic analysis support the identification of children and adults with pre-symptomatic T1D? - Richard Oram, Exeter (11:30 - 11:50)

Research studies into monitoring of pre-T1D

Chairs: Renuka Dias & Emily Sims

Current UK research monitoring studies in children - Loredana Marcovecchio, Cambridge (11:50 - 12:10) 

Current UK research monitoring studies in adults - Anna Long, Bristol (12:10 - 12:40) 

Day 1 - Session 3 - 13:40 - 15:10

Optimising Av assays for T1D screening - Alex Richter, Birmingham (13:40 - 14:00)

Managing pre-symptomatic T1D in UK clinical practice

Chairs: Fiona Campbell & Danijela Tatovic

Monitoring children in UK clinical practice and the UK Ab registry - Rachel Besser, Oxford (14:00 - 14:40)

Accurate disease classification and monitoring of pre-symptomatic T1D in adults - Nick Thomas, Exeter (14:20 - 14:40)

Panel discussion with Marc Atkin and Fulya Mehta, led by Fiona Campbell and Danijela Tatovic (14:40 - 15:10)

Day 2 - Session 1 - 09:00 - 10:50

Psychological Impact

Chair: Olga Boiko

The psychological impact of early T1D, a summary of evidence so far - Olga Boiko, Birmingham (09:00 - 09:20)

Prediction and prevention of rheumatoid arthritis: Perspectives of people at risk, patients and healthcare professionals - Marie Falahee, University of Birmingham (09:20 - 09:40)

Living with chronic uncertainty, examples form Cystic Fibrosis (CFSPID) - Felicity Boardman, University of Birmingham (09:40 - 10:00)

A patient experience of screening - 10 mins for family and adult (ELSA, T1DRA)

Panel discussion with all speakers (10:30 - 10:50)

Day 2 - Session 2 - 11:20 - 13:00

Disease Modifying Therapy for T1D

Chairs: Tim Tree & Colin Dayan

Lessons from MS - Gavin Giovannoni , London (11:20 - 11:40)

The US Experience - Kimber Simmons, Denver (11:40 - 12:00)

The UK Experience - Renuka Dias, Birmingham and Neil Wright, Sheffield (12:00 - 12:20)

Navigating the practicalities of accessing and delivering a 14-day therapy - Phil Newland Jones, Southampton (12:20 - 12:40)

Panel Discussion (12:40- 13:00)

Day 2 - Session 3 - 14:00 - 15:00 

The Future

Chairs: Susan Wong & Rachel Connor

Pipeline of DMTs in T1D - Emily Sims (14:00 - 14:30)

The T1DRC, Platform trials and the future - Colin Dayan, Cardiff (14:30 - 15:00)

Outstanding recordings to follow shortly, please check back.